FDA Urged To Pull Eisai's High-Dose Aricept
By Allison Grande · May 19, 2011, 5:46 PM EDT
A nonprofit consumer advocacy group urged the U.S. Food and Drug Administration on Wednesday to immediately yank the highest dose of Alzheimer's disease drug Aricept from the market due to its...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login